Literature DB >> 18499027

Enteric autoantibodies and gut motility disorders.

Purna Kashyap1, Gianrico Farrugia.   

Abstract

Increasing evidence suggests that a subset of gastrointestinal motility disorders is associated with the presence of circulating antibodies. These antibodies are directed against various molecular targets, the best known being anti-neuronal nuclear antibody (ANNA-1 or anti-Hu) associated with paraneoplastic motility disorders. There is also evidence that the presence of distinct autoantibody profiles is associated with non-paraneoplastic motility disorders. This review focuses on the types of antibodies associated with gastrointestinal motility disorders and the significance of these antibodies. Algorithms are suggested for the work-up and treatment of patients with circulating antibodies associated with gastrointestinal motility disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18499027      PMCID: PMC2448392          DOI: 10.1016/j.gtc.2008.02.005

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  62 in total

1.  Immunological concomitants of myasthenia gravis.

Authors:  A J Strauss; H W van der Geld; P G Kemp; E D Exum; H C Goodman
Journal:  Ann N Y Acad Sci       Date:  1965-06-30       Impact factor: 5.691

2.  Pancreatic carcinoma is associated with delayed gastric emptying.

Authors:  J S Barkin; R I Goldberg; G N Sfakianakis; J Levi
Journal:  Dig Dis Sci       Date:  1986-03       Impact factor: 3.199

3.  Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume.

Authors:  D J Hetzel; C R Stanhope; B P O'Neill; V A Lennon
Journal:  Mayo Clin Proc       Date:  1990-12       Impact factor: 7.616

4.  Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

Authors:  F A Luque; H M Furneaux; R Ferziger; M K Rosenblum; S H Wray; S C Schold; M J Glantz; K A Jaeckle; H Biran; M Lesser
Journal:  Ann Neurol       Date:  1991-03       Impact factor: 10.422

5.  Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma.

Authors:  V A Lennon; D F Sas; M F Busk; B Scheithauer; J R Malagelada; M Camilleri; L J Miller
Journal:  Gastroenterology       Date:  1991-01       Impact factor: 22.682

6.  Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma.

Authors:  J E Greenlee; H R Brashear
Journal:  Ann Neurol       Date:  1983-12       Impact factor: 10.422

7.  Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia.

Authors:  R H Holloway; W J Dodds; J F Helm; W J Hogan; J Dent; R C Arndorfer
Journal:  Gastroenterology       Date:  1986-04       Impact factor: 22.682

8.  Eosinophilic myenteric ganglionitis is associated with functional intestinal obstruction.

Authors:  M G Schäppi; V V Smith; P J Milla; K J Lindley
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

9.  Intestinal pseudoobstruction caused by diffuse lymphoid infiltration of the small intestine.

Authors:  G B McDonald; M D Schuffler; M E Kadin; G N Tytgat
Journal:  Gastroenterology       Date:  1985-10       Impact factor: 22.682

10.  Thymic B lymphocyte clones from patients with myasthenia gravis secrete monoclonal striational autoantibodies reacting with myosin, alpha actinin, or actin.

Authors:  C L Williams; V A Lennon
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  12 in total

1.  Enteric Nervous System: Neuropathic Gastrointestinal Motility.

Authors:  Jackie D Wood
Journal:  Dig Dis Sci       Date:  2016-07       Impact factor: 3.199

Review 2.  Esophageal motility disorders: new perspectives from high-resolution manometry and histopathology.

Authors:  Hiroki Sato; Kazuya Takahashi; Ken-Ichi Mizuno; Satoru Hashimoto; Junji Yokoyama; Go Hasegawa; Shuji Terai
Journal:  J Gastroenterol       Date:  2017-11-13       Impact factor: 7.527

Review 3.  Immunity, Ion Channels and Epilepsy.

Authors:  Tsang-Shan Chen; Ming-Chi Lai; Huai-Ying Ingrid Huang; Sheng-Nan Wu; Chin-Wei Huang
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

Review 4.  Epigenetics and chromatin dynamics: a review and a paradigm for functional disorders.

Authors:  T Ordog; S A Syed; Y Hayashi; D T Asuzu
Journal:  Neurogastroenterol Motil       Date:  2012-10-24       Impact factor: 3.598

5.  Gastroparesis as the initial presentation of pulmonary adenocarcinoma.

Authors:  Gaurang Nandkishor Vaidya; Denyse Lutchmansingh; Manju Paul; Savio John
Journal:  BMJ Case Rep       Date:  2014-12-09

6.  Innovative gastric endoscopic muscle biopsy to identify all cell types, including myenteric neurons and interstitial cells of Cajal in patients with idiopathic gastroparesis: a feasibility study (with video).

Authors:  Elizabeth Rajan; Christopher J Gostout; Louis M Wong Kee Song; Lawrence A Szarka; Purna C Kashyap; Thomas C Smyrk; Juliane Bingener; Jodie L Deters; Mary A Knipschield; Cheryl E Bernard; Gianrico Farrugia
Journal:  Gastrointest Endosc       Date:  2016-04-27       Impact factor: 9.427

Review 7.  New techniques in the tissue diagnosis of gastrointestinal neuromuscular diseases.

Authors:  Charles H Knowles; Joanne E Martin
Journal:  World J Gastroenterol       Date:  2009-01-14       Impact factor: 5.742

Review 8.  Cellular pathogenesis of diabetic gastroenteropathy.

Authors:  T Ordög; Y Hayashi; S J Gibbons
Journal:  Minerva Gastroenterol Dietol       Date:  2009-09

9.  Anti-enteric neuronal antibodies and the irritable bowel syndrome.

Authors:  Jackie D Wood; Sumei Liu; Douglas A Drossman; Yehuda Ringel; William E Whitehead
Journal:  J Neurogastroenterol Motil       Date:  2012-01-16       Impact factor: 4.924

Review 10.  Gonadotropin-Releasing Hormone and Its Role in the Enteric Nervous System.

Authors:  Bodil Ohlsson
Journal:  Front Endocrinol (Lausanne)       Date:  2017-06-07       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.